Given Dr. Cummings' statement in yesterday's PR about the promising effects that BETonMACE data shows vis a vis cognition it seems to me that the market should already have good news baked in to RVX's valuation.
More important I believe is the following day's webcast....will we find out anything further about partnerships or the company's financial state? Fully exercised this warrant incentive program will simply keeps the dogs barking at the door quiet for maybe another 3 or 4 months but I don't think its anywhere near enough to advance Apabetalone.....
By my reckoning I figure they need somewhere between $40 to $50 million per year to advance Apabetalone toward approval...right now I think they're just playing catch up with this incentive program, and we won't know if it worked or to what degree for a few weeks yet.
Bring on some volume today....